Coming soon: LGBTQIA+ Affirming Provider Designation toolkits

Dec. 2023Important Notices
In the coming weeks, we will send the LGBTQIA+ Affirming Provider Designation toolkits to providers who have earned the designation to date. These kits include a provider welcome letter, postcard, badge reel, lapel pin, table tent, and talking points for office staff. Please note that this shipment requires a signature for delivery.

Interested in earning the designation?
We encourage all providers to earn the LGBTQIA+ Affirming Provider Designation. To get started, complete these three modules:

Recent Announcements

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates